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Abstract Article Info 
Introduction: Nasopharyngeal cancer is the most common malignant tumor found among any other malignant 
ENT tumors in Indonesia. Nasopharyngeal cancer (NPC) is a unique epithelial malignancy arising from the 
superior aspect of the pharyngeal mucosal space associated with latent Epstein-Barr virus infection in most 
cases. Nasopharyngeal cancer is generally more common in Southeast Asia. The five countries with the highest 
incidence of nasopharyngeal cancer in the world were China, Indonesia, Vietnam, India, and Malaysia, 
respectively.  
Objective: The aim of this study was to investigate the effects of characteristics of distant metastases in 
nasopharyngeal cancer patients in the Otorhinolaryngology-HNS Department Haji Adam Malik General 
Hospital Medan during 2014-2016. 
Methods: This was an observational descriptive study with a cross-sectional design in a retrospective 
manner, where this study aimed to look at how the characteristics of distant metastasis in patients with 
nasopharyngeal cancer 
Results: From all over the subject, distant metastases most common in liver 52 (24.5%), follow by Renal 
function impairment 18 (8.5%), Lung metastasis 10 (4.7%), Heart Impairment 10 (4.7%). 
Conclusion: Most people with nasopharyngeal cancer come from the age group 38-47 years (31.6%). Most 
sufferers of nasopharyngeal cancer are men (69.3%). The state of disease in nasopharyngeal cancer with the 
highest incidence rate is stage IV (63.7%). Most organ impairment found in patients with nasopharyngeal cancer 
is liver disorder (24.5%). 
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Nasopharyngeal cancer (NPC) is the most common malignant tumor that 
grows in the nasopharynx. Nasopharyngeal cancer (NPC) is a rare malignancy 
worldwide, but it is endemic in a few areas in Asia with underlying 
mechanisms behind this remarkable geographic distribution remain unclear 
[1]. Nasopharyngeal Cancer is cancer originating from epithelial cells in the 
inner and outer wall of the nasopharynx [2]. Nasopharyngeal cancer (NPC) is 
a unique epithelial malignancy arising from the superior aspect of the 
pharyngeal mucosal space associated with latent Epstein-Barr virus infection 
in most cases [3]. In NPC, the virus exists in a latent state, exclusively in the 
tumor cells, and absent from the surrounding lymphoid infiltrate. However, the 
interaction between the prominent lymphoid stroma found in undifferentiated 
NPC and adjacent cancer cells appears to be crucial for the continued growth 
of malignant NPC cells [4]. NPC is the most frequent cancer in the head and 
neck region in Indonesia. This cancer is very sensitive to radiotherapy with 
resulting in 3 year disease-free and overall survival of approximately 70% and 
80%, respectively [5].  
Nasopharyngeal cancer is generally more common in Southeast Asia, 
especially in China, Indonesia, Vietnam, India, and Malaysia, respectively. 
From all over the world, the standard incidence of nasopharyngeal cancer 
was 1.2 per 100,000 (in men 1.7 per 100,000; in women, 0.7 per 100,000) 
[6].  In the United States and the rest of the world, the incidence of less than 
1 case per 100,000 people per year is reported [7]. Farhat 2018 has reported, 
the largest age group of a patient diagnosed with NPC is between 41-60 
years old (57.1%) [8]. 
In Indonesia, Nasopharyngeal Cancer (NPC) is the most frequent 
cancer of the head and neck region, and the recorded mean prevalence is 
6.2/100 000, with 13.000 new cases every year, but otherwise little is 
documented on NPC in Indonesia [9, 10]. The prevalence of nasopharyngeal 
cancer in Indonesia is 3.9 per 100,000 population each year. In the H. Adam 
Malik General Hospital in Medan, North Sumatra Province, the majority of 
NPC patients are Men (compared with women 2.84: 1), 50-59 years 
(29.2%), and farming (32.3%). The Batak ethnic is the largest ethnic group 
suffering from NPC 54 people (56.3%) and followed in second place the 
most are Javanese (29.2%) [11]. Report from ENT Departement outpatient 
Haji Adam Malik Hospital Medan in 2006-2010, 335 cases were found new 
Nasopharyngeal Cancer [12].  
The most common presenting sign of NPC is a unilateral neck mass 
(approximately 80% cases). A previous study in Cipto Mangunkusumo 
General Hospital showed a neck lump presented in 58.1% [13]. Metastasis 
is the spread of tumors from the first location appearing as a primary tumor 
to another location in the body. Metastasis depends on 2 influence factors, 
namely cell motility and the degree of invasion. Basically, metastatic cells 
are the same as cells in the primary tumor. The metastases that occur can be 
far or distant and near metastases. The most common metastatic sites are 
bone (70-80%), followed by visceral organs (30% liver, 18% lung) and 
followed by lymph nodes that are not in the cervical region (axillary folds, 
mediastinal, pelvic, and inguinal) [14]. 
According to Jia-xin li et al. distant metastasis in NPC patients 
conventionally has been considered incurable, and all forms of treatment are 
only palliative therapy. The average survival time ranges from 12.9-26.8 
months. Nevertheless, the results may change in clinical practice. Some 
patients can survive up to 5 years or even more [15]. 
 
2. MATERIALS AND METHODS 
This research is an observational descriptive study with a cross-
sectional design in a retrospective manner, where this study aimed to look 
at how the characteristics of distant metastasis in patients with 
nasopharyngeal cancer. The population of this study was 396 patients with 
nasopharyngeal cancer in H. Adam Malik Medan General Hospital in 2014-
2016. The sampling technique used in this study was total sampling where 
the research subjects were NPC patients in H. Adam Malik Medan General 
Hospital who fulfilled the inclusion criteria. Inclusion criteria is diagnosed 
with nasopharyngeal cancer by a doctor, and exclusion criteria is incomplete 
medical record data. 








Table 1. Characteristics of Nasopharyngeal Cancer Patient 
Characteristics N (=212) % 
Age Group   
0-17 6 2.8 
18-27 16 7.5 
28-37 21 9.9 
38-47 67 31.6 
48-57 65 30.7 
58-67 29 13.7 
68-77 4 1.9 
78-87 4 1.9 
Gender   
Male 147 69.3 
Female 65 30.7 




Primary school 32 15.1 
Junior high school 43 20.3 
Senior high school 118 55.7 
Bachelor 15 7.1 
Stage of Disease   
I 2 0.9 
II 9 4.2 
III 66 31.1 
IV 135 63.7 













Yes 52 (24.5%) 18 (8.5%) 10 (4.7%) 10 (4.7%) 2 (0.9%) 
No 160 (75.5%) 194 (91.5%) 202 (95.3%) 202 (95.3%) 210 (99.1%) 
Total 212 (100%) 212 (100%) 212 (100%) 212 (100%) 212 (100%) 
This research has been held at the medical record installation of Haji 
Adam Malik General Hospital in Medan, with a total sample of 212 people. 
Characteristics studied were age, sex, education, stage, and incidence of 
distant metastasis in patients with nasopharyngeal cancer. 
In the description of the incidence of nasopharyngeal cancer based on 
age, the incidence of nasopharyngeal cancer is most commonly found in the 
age group 38-47 years, ie 67 people (31.6%), followed by the age group 48-
57 years as many as 65 people (30.7%), 58-67 years old as many as 29 
people (13.7%), 28-37 years old as many as 21 people (9.9%), 18-27 years 
old as many as 16 people (7.5%), 0-17 years old as many as 6 people (2.8%), 
age 68-77 years and 78-87 years each 4 people (1.9%). The incidence of 
nasopharyngeal cancer in male (69.3%) and female (30.7%). 
Nasopharyngeal cancer patients with senior high school as their last 
education were 118 people (55.7%), then junior high school 43 people 
(20.3%), elementary school 32 people (15.1%), undergraduate 15 people 
(7.1%), and did not graduate from elementary school namely 4 people 
(1.9%). Patients with nasopharyngeal cancer are diagnosed with stage I as 
many as 2 people (0.9%), stage II 9 people (4.2%), stage III 66 people 
(31.1%), stage IV 135 people (63.7%). 
In table 2, it can be seen that organ damage that is most often found is 
liver dysfunction as many as 52 people (24.5%), then impaired kidney 
function in 18 people (8.5%), pulmonary metastases and heart problems 
respectively 10 people (4.7%), and others in 2 people (0.9%). 
4. DISCUSSION 
This study aims to see the description of distant metastases in patients 
with nasopharyngeal cancer in H. Adam Malik Medan General Hospital in 
2014-2016 by looking at several characteristics. The characteristic of the 
age of the patient in this study similar according to Adham's research which 
showed that the peak incidence of nasopharyngeal cancer in Indonesia at the 
age of 40 to 49 years, and more than 80% of patients with nasopharyngeal 
cancer were diagnosed for the first time in the age range of 30 to 59 years 
[9]. The characteristic of the gender of the patients in this study similar 
according to Wei et al. research in China in 2013 which said that the 
incidence of nasopharyngeal cancer in male was higher than in female with 
15,730 cases of nasopharyngeal cancer were found in men, and 5580 cases 
found in women [16].  
The last education of patients with nasopharyngeal cancer in this study 
had a high incidence rate in patients with senior high school as their last 
education which was 118 people (55.7%). Samples with nasopharyngeal 
cancer most diagnosed in stage IV, as many as 135 people (63.7%). 
In this study, the most common organ damage was liver dysfunction. 
The research conducted by Bensouda et al. in 2011 stating that the most 
common location of metastases found in patients with nasopharyngeal 
cancer is bone (70-80% of cases), 30% of the visceral organ like the liver, 
and 18% of lungs. Metastases are less common found in lymph nodes 
outside neck (axilla, mediastinal, pelvic, and inguinal) [14]. In this study 
there was no examination of bone metastasis due to lack of facilities at the 
place where the study was conducted. 
5. CONCLUSION 
Most people with nasopharyngeal cancer come from the age group 38-
47 years (31.6%). Most sufferers of nasopharyngeal cancer are men 
(69.3%). The state of disease in nasopharyngeal cancer with the highest 
incidence rate is stage IV (63.7%). Most organ impairment found in patients 
with nasopharyngeal cancer is liver disorder (24.5%). For the Haji Adam 
Malik General Hospital in Medan, it is expected to be able to complete 
facilities related to diagnosing metastasis in NPC patients such as bone scan, 
liver, and kidney ultrasound, and can complete medical records data. For the 
next researcher it is expected to complete the limitation of this study by 
adding more variable variations. 
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